psychable.png
While Suicide Remains A Leading Cause Of Death In The U.S., Depression Treatment Options Expand as Psychedelic-Assisted Therapy Proves to be an Increasingly Effective Approach to Transformative Mental Health
September 06, 2021 08:00 ET | Psychable, Inc.
This Suicide Prevention Week, Psychable Offers Comprehensive Information on Treatment Options and Safe Access to Practitioners Through Supportive Online Community LOS ANGELES, Sept. 06, 2021 ...
psychable.png
National Recovery Month: Interest in Psychedelic-Assisted Therapy to Treat Addiction Grows as Substance Abuse Skyrockets Amidst Backdrop of Pandemic
September 01, 2021 09:00 ET | Psychable, Inc.
Psychable Online Community Connects Those Seeking Treatment with Knowledgeable Psychedelic Professionals in a Trusted and Safe Space LOS ANGELES, Sept. 01, 2021 (GLOBE NEWSWIRE) -- With a...
ibn-iw-globe-2.png
InvestorBrandNetwork (IBN) Announces Latest Episode of The Bell2Bell Podcast featuring Kelsey Ramsden, Co-Founder & CEO of Mind Cure Health Inc.
August 19, 2021 08:17 ET | InvestorBrandNetwork (IBN)
NEW YORK, Aug. 19, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- InvestorBrandNetwork (“IBN”), a multifaceted communications organization engaged in connecting public companies to the investment...
NEW ATAI-Logo_Primary.png
atai Life Sciences Reports Second Quarter 2021 Financial Results and Business Update
August 16, 2021 07:00 ET | atai Life Sciences
-Successfully completed Initial Public Offering on Nasdaq raising $258.8 million in gross proceeds, including the underwriters’ over-allotment- -Received $20 million upfront payment from Otsuka as...
NEW ATAI-Logo_Primary.png
atai Launches Revixia Life Sciences to Develop Salvinorin A for a Variety of Mental Health Conditions
August 12, 2021 08:50 ET | atai Life Sciences
BERLIN, Aug. 12, 2021 (GLOBE NEWSWIRE) -- atai Life Sciences (Nasdaq: ATAI) ("atai"), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders,...
NEW ATAI-Logo_Primary.png
atai Life Sciences to Present at the 41st Annual Canaccord Genuity Growth Conference
August 06, 2021 18:10 ET | atai Life Sciences
BERLIN, Aug. 06, 2021 (GLOBE NEWSWIRE) -- atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders,...
New poll shows a strong base of Canadians overwhelmingly support controlled legal access to psilocybin-assisted therapy; Canadian Psychedelic Association responds with Memorandum of Regulatory Approval (MORA)
August 04, 2021 07:02 ET | Canadian Psychedelic Association
Vancouver, BC, Aug. 04, 2021 (GLOBE NEWSWIRE) -- A Nanos Research Survey released today by the Canadian Psychedelic Association (CPA) shows 82 percent of Canadians approve the use of...
ibn-iw-globe-2.png
InvestorBrandNetwork Announces The Dealmaker Show Interview with Tryp Therapeutics Inc. CEO Greg McKee
August 03, 2021 08:00 ET | InvestorBrandNetwork (IBN)
LOS ANGELES, Aug. 03, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities, today announces...
NEW ATAI-Logo_Primary.png
atai Life Sciences launches InnarisBio, in partnership with the University of Queensland, with the aim to develop a more effective nose-to-brain delivery method for atai’s platform of mental health therapeutic programs
July 28, 2021 09:12 ET | atai Life Sciences
BERLIN and BRISBANE, Australia, July 28, 2021 (GLOBE NEWSWIRE) -- atai Life Sciences (“atai” or the “Company”) (Nasdaq: ATAI), a clinical-stage biopharmaceutical company aiming to transform the...
The Psychedelic Capital: July 2021 Conference Returns Seeks to Present Attendees With Insights Into the Latest Trends, Companies and Developments Within the Global Psychedelics Industry
July 22, 2021 10:07 ET | Microdose Psychedelic Insights
NEW YORK, July 22, 2021 (GLOBE NEWSWIRE) -- via NetworkNewsWire -- Microdose Psychedelic Insights, a cutting-edge media company focused around promoting content, financial analysis, and engaging...